Emerald BioScience (OTCQB:EMBI) CEO Brian Murphy spoke to Proactive at the Biotech Showcase 2020 in San Francisco. The Long Beach, California-based biopharmaceutical company is focused on the discovery, development, and commercialization of bioengineered cannabinoid-based therapeutics.
Emerald Bioscience reveals recent milestones with its CBD-based therapeutic
Quick facts: Emerald Bioscience Inc.
Price: 0.151 USD
Market Cap: $27.66 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE